The associations between polymorphisms in the CD36 gene, fat oxidation and cardiovascular disease risk factors in a young adult Australian population: A pilot study
- 1 November 2014
- journal article
- Published by Elsevier in Obesity Research & Clinical Practice
- Vol. 8 (6) , e618-e621
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- The genetics of human obesityAnnals of the New York Academy of Sciences, 2013
- CD36 genetics and the metabolic complications of obesityCurrent Opinion in Clinical Nutrition and Metabolic Care, 2011
- Methods to Standardize Dietary Intake Before Performance TestingInternational Journal of Sport Nutrition and Exercise Metabolism, 2010
- Membrane Fatty Acid Transporters as Regulators of Lipid Metabolism: Implications for Metabolic DiseasePhysiological Reviews, 2010
- G*Power 3: A flexible statistical power analysis program for the social, behavioral, and biomedical sciencesBehavior Research Methods, 2007
- Attenuated aerobic exercise capacity in CD36 deficiencyJournal of Medical Genetics, 2007
- Direct association of a promoter polymorphism in the CD36/FAT fatty acid transporter gene with Type 2 diabetes mellitus and insulin resistanceDiabetic Medicine, 2006
- A common haplotype at the CD36 locus is associated with high free fatty acid levels and increased cardiovascular risk in CaucasiansHuman Molecular Genetics, 2004
- A CD36 nonsense mutation associated with insulin resistance and familial type 2 diabetesHuman Mutation, 2004
- CD36: a class B scavenger receptor involved in angiogenesis, atherosclerosis, inflammation, and lipid metabolismJournal of Clinical Investigation, 2001